Viramune (Nevirapine) – Patient Information for Australian Patients
1. Basic Product Information
| International Non-proprietary Name (INN) | Nevirapine |
|---|---|
| Australian Brand Names | Viramune®, Viramune XR® |
| ATC Code | J05AG01 |
| Available Forms and Strengths | Tablets: 200 mg Prolonged-release tablets (XR): 400 mg Oral suspension: 50 mg/5 mL |
| Manufacturers | Boehringer Ingelheim Pty Ltd |
| Prescription Status | Prescription only (Schedule 4, S4 medicine in Australia) |
2. How Viramune (Nevirapine) Works
Simple Overview
Viramune contains nevirapine, an antiretroviral medication used to treat HIV-1 infection. It helps reduce the amount of HIV (the virus that causes AIDS) in your body and strengthens your immune system. Taking Viramune does not cure HIV, but it can help you live a healthier, longer life when combined with other HIV medicines.
Detailed Mechanism (for Specialists)
Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It binds directly to reverse transcriptase, an enzyme critical for HIV replication, causing a conformational change that inhibits enzymatic function. This results in interruption of viral RNA-dependent DNA polymerase activity and halts viral replication in infected cells.
3. Pharmacokinetics
- Absorption: Rapid and almost complete (bioavailability >90%) after oral administration. Peak levels occur 4 hours post-dose.
- Distribution: Widely distributed in body tissues and fluids; crosses the placenta and is present in breast milk.
- Metabolism: Extensively metabolised in the liver via cytochrome P450 enzymes (primarily CYP3A4 and CYP2B6).
- Elimination: Mainly eliminated in urine as metabolites (80%); terminal plasma half-life approximately 25–30 hours after repeated dosing.
- Duration: Once daily with XR (extended release) formulation; twice daily with standard tablets after initial lead-in period.
4. Everyday Use and Best Practices in Australia
Viramune is most effective when taken exactly as prescribed by your doctor, usually as part of combination antiretroviral therapy (ART).
- Adults: Typically start with 200 mg once daily for 14 days (“lead-in” period to reduce risk of rash), then increase to 200 mg twice daily.
- XR (prolonged-release) formulation: After lead-in, switch to 400 mg once daily if tolerated.
- Oral suspension is available for children or adults unable to swallow tablets.
- Check with your doctor or pharmacist about other medicines, including over-the-counter, herbal, or vitamin supplements.
- If you miss a dose, take it as soon as you remember (unless close to your next dose; never double up).
- Always use in combination with other antiretrovirals as part of a prescribed regimen.
5. Morning vs Evening Dosing
- Advantages of Morning Dosing:
- Helps establish a routine—may improve adherence.
- Monitor for side effects during the day; easier access to support.
- Advantages of Evening Dosing:
- May align with other daily medicines/habits.
- Some prefer evening doses to sleep through mild side effects (e.g., fatigue, dizziness).
- Best Practice:
- Choose a convenient time and stick to it daily.
- Discuss with your doctor or pharmacist to fit your routine—consistency is key.
6. Taking with Food or on an Empty Stomach
Nevirapine can be taken with or without food. Eating before or after your dose does not significantly affect absorption or effectiveness. For Australian patients, this means you may take your medicine with a light meal, typical breakfast, or dinner food as is your habit. If you have sensitive digestion, taking with food or a snack (such as toast or a glass of milk) may reduce mild stomach upset.
Note for Australian Diet: Nevirapine does not interact with most common foods, bread, dairy, or meat. Grapefruit and grapefruit juice are not known to affect nevirapine, unlike some other medicines—but check with your healthcare provider if unsure. No adjustments are needed for vegetarians or vegans.
7. Interaction Warnings
| Interacting Substance | Interaction Effect | Advice |
|---|---|---|
| St. John’s wort | May lower nevirapine levels, risking treatment failure | Avoid use |
| Rifampicin, rifabutin (TB medicines) | Can lower nevirapine levels | Consult your doctor |
| Ketoconazole, itraconazole (antifungals) | Can affect blood levels of both medicines | May need alternatives or close monitoring |
| Hormonal contraceptives | May reduce effectiveness of oral contraceptives | Consider additional contraception |
| Other antiretrovirals (e.g., efavirenz) | Potential interactions | Take only as recommended by HIV specialist |
| Alcohol | May increase risk of liver side effects | Limit or avoid alcohol |
| Warfarin | May alter blood-thinning effect | Regular blood tests needed |
Always let your prescriber and pharmacist know about all medications, supplements, or herbal remedies you are taking.
8. Indications
| Indication | Status |
|---|---|
| Treatment of HIV-1 infection (in combination with other antiretroviral agents) | Official (TGA-approved in Australia) |
| Prevention of mother-to-child transmission of HIV-1 | Off-label/Supported by international guidelines |
| Post-exposure prophylaxis (PEP) for HIV | Off-label/Occasional use per specialist advice |
9. Dosing According to Clinical Indications
| Population | Standard Dose | Special Notes |
|---|---|---|
| Adults | 200 mg once daily for 14 days, then 200 mg twice daily OR 400 mg once daily with XR after lead-in | Lead-in period reduces risk of rash/liver side effects |
| Paediatric (2 months – 18 years) | Dosage by body weight or surface area (as per specialist); typically 120–150 mg/m2 once daily for 14 days, then twice daily | Oral suspension available |
| Elderly (over 65 years) | Same as adult dose | Monitor closely for liver/kidney side effects |
| Liver or kidney impairment | Use with caution or avoid | May require specialist assessment or alternative therapy |
10. Safety Profile and Side Effects
| Type | Common Side Effects | Rare but Serious Reactions | Warnings |
|---|---|---|---|
| Skin | Rash (mild to moderate, usually in first 6 weeks) | Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) | Stop and seek help if severe rash, blisters, or mouth ulcers appear |
| Liver | Elevated liver enzymes, mild hepatitis | Serious liver damage, liver failure (rare, can be fatal) | Alert for abdominal pain, yellow skin/eyes, or severe nausea—see doctor urgently |
| Other | Fever, headache, nausea, fatigue | Hypersensitivity reactions (fever, joint pain, eye swelling) | Tell your doctor about any unusual symptoms |
Liver tests are routinely checked before and during treatment in Australia. The risk is highest in the first 18 weeks, so close monitoring is essential.
11. Guidelines for Proper Use (Australia)
- Always follow your specialist’s instructions—never change or stop your medicine on your own.
- Attend all scheduled blood tests to monitor your liver and kidney function.
- Use a medicine diary, phone reminder, or pharmacy dose administration aid (DAA) to help stay on track.
- Return unused or expired medicines to your pharmacy for safe disposal (as per Australia guidelines).
- If you travel within Australia, keep your medicine in its original packaging with your prescription label at all times.
- Australian pharmacists can offer extra support—ask about medicine reviews, dose packing, or vaccination reminders.
12. Alternative Treatment Options
- Efavirenz (Stocrin, Atripla): Another NNRTI, once-daily dosing, but may cause more vivid dreams or mood effects.
- Etravirine, Rilpivirine: Later-generation NNRTIs, often better tolerated, different resistance profiles—PBS subsidised for eligible patients.
- Integrase inhibitors (e.g., dolutegravir, bictegravir): Preferred initial therapy in Australia per current guidelines—higher barrier to resistance. Greater availability on the PBS.
- Protease inhibitors (PIs, such as darunavir, atazanavir): Alternative class, often used in combination regimens.
Pros and Cons of Nevirapine: Useful in certain settings, such as breastfeeding mothers with HIV or when other regimens are unsuitable. Higher risk of serious skin and liver reactions than newer antiretrovirals, so not usually first choice. Discuss all options with your HIV clinic.
13. Legal, Registration, and Reimbursement Status in Australia
- Registration: Registered with the Therapeutic Goods Administration (TGA)
- Prescription Requirement: Schedule 4 (S4)—prescription only by medical practitioner
- Reimbursement: Listed on the Pharmaceutical Benefits Scheme (PBS) for eligible patients, typically with specialist prescription
- Supply Chain: Supplied through hospital and community pharmacies across Australia
- Notifiable conditions: HIV is a notifiable disease; your details remain confidential under Australia law
14. Latest Research and Clinical Guidance (2022–2025)
- Nevirapine remains effective for certain populations but is now less commonly prescribed as first-line due to side effect profile (ASHM HIV Management Guidelines, 2023).
- Current Australian guidance from ASHM advises use if alternative agents are unsuitable, or in special circumstances (e.g., pregnancy, rural supply issues) – see TGA and PBS for updates.
- No new safety concerns have emerged since 2021, but regular liver monitoring remains essential.
- Global data supports once-daily XR formulation as equivalent in efficacy, with potentially better adherence outcomes (PubMed, 2022).
15. Availability and Delivery in Australia
| Pack Size | Form | Approximate PBS Price | Indicative Delivery Times |
|---|---|---|---|
| 60 tablets | Viramune 200 mg tablets | $40–$50 PBS co-payment | Sydney, Melbourne: 1–2 business days Brisbane, Perth, Adelaide: 2–3 business days Hobart, Darwin: 3–5 business days |
| 30 tablets | Viramune XR 400 mg | $40–$50 PBS co-payment | Sydney, Melbourne: 1–2 business days Regional/remote areas: 3–5 business days (may vary) |
| 240 mL bottle | Oral suspension, 50 mg/5 mL | $40–$50 PBS co-payment | Available at most hospital and selected community pharmacies (order ahead recommended) |
16. Frequently Asked Questions (FAQ)
Q1: What should I do if I miss a dose?
Take the missed dose as soon as you remember, unless it is close to your next scheduled dose. Never take a double dose. If unsure, ask your pharmacist.
Q2: Is Viramune safe in pregnancy or breastfeeding?
Yes, nevirapine can be used in pregnancy and breastfeeding under specialist care, and has been used for mother-to-child transmission prevention in Australia. Your HIV doctor will help you decide the safest treatment.
Q3: Can I drink alcohol while taking Viramune?
Avoid or limit alcohol—drinking increases the risk of liver side effects with nevirapine.
Q4: What should I do if I develop a rash or feel unwell?
Contact your doctor immediately if you develop a new rash, skin peeling, yellowing of eyes/skin, severe abdominal pain, or flu-like illness. These can signal rare but serious reactions.
Q5: How long will I need to take Viramune?
HIV is a chronic condition—medicines are generally continued lifelong. Do not stop Viramune unless advised by your doctor.
